I will agree that earnings are a big key in the fu
Post# of 15624
![](/assets/46931549/no_avatar_available_thumb.jpg)
The point is, we have no idea what discussions may be going on between the company, and those who may be interested in it. One investor mentioned California rights, that too could be quite big. Money from any deal could dramatically influence share price and we know nothing about what may be in discussion.
That said, I still believe the ultimate goal of the company is a buyout that will be a multi-billion dollar deal. I don't expect it for at least a few years, but anything is possible once the company gains patent approval for many of its drugs, without that it's just discussion.
Gary
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)